In Portugal, data on drug-related infectious diseases are available from drug treatment facilities and provide insights into some subgroups of drug users: (i) those demanding treatment for the first time at the public network of outpatient treatment facilities; (ii) those admitted to public detoxification treatment units or certified private detoxification units; and (iii) those in treatment in public or certified private therapeutic communities.
A decreasing trend in the number of notifications of human immunodeficiency virus (HIV) infections linked to injecting drug use has been observed since the early 2000s in Portugal. In 2017, the proportion of new HIV notifications associated with injecting drug use was around 2 %.
|Data from 2017.|
In 2017, 13 % of drug users who had ever injected drugs and who were tested at outpatient treatment services were HIV positive.
Among injecting drug users admitted to treatment in 2017, the rate of hepatitis C virus (HCV) infection was 81.5 %, with the prevalence of chronic hepatitis B virus (HBV) infection ranging between 3 % and 6 %.